Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Jones

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Human Vaccines & Immunotherapeutics|December 20, 2012
Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B diseaseAnnaliesa S Anderson, Li Hao, Qin Jiang, et al.
The Pediatric Infectious Disease Journal|November 2, 2012
A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescentsMichael D Nissen, Helen S Marshall, Peter C Richmond, et al.
Plos One|April 25, 2014
A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderlyC Raina Macintyre, Iman Ridda, Zhanhai Gao, et al.
Molecular Psychiatry|December 2, 2021
Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomesZhi-De Deng, Miklos Argyelan, Jeremy Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
The role of the IL-2 pathway in costimulation blockade-resistant rejection of allograftsThomas R Jones, Jongwon Ha, Matthew A Williams, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 12, 2020
Electroconvulsive Therapy Pulse Amplitude and Clinical OutcomesChristopher C Abbott, Davin Quinn, Jeremy Miller, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B DiseaseGary W Zlotnick, Thomas R Jones, Paul Liberator, et al.
Vaccine|May 22, 2013
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccineLisa A Jackson, Alejandra Gurtman, Kathryn Rice, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2003
Thiourea inhibitors of herpes viruses. Part 1: bis-(aryl)thiourea inhibitors of CMVJonathan D Bloom, Martin J DiGrandi, Russell G Dushin, et al.
Journal of the Pediatric Infectious Diseases Society|January 25, 2016
Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy AdolescentsTimo Vesikari, Jacek Wysocki, Johannes Beeslaar, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Human Vaccines & Immunotherapeutics|December 20, 2012
Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B diseaseAnnaliesa S Anderson, Li Hao, Qin Jiang, et al.
The Pediatric Infectious Disease Journal|November 2, 2012
A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescentsMichael D Nissen, Helen S Marshall, Peter C Richmond, et al.
Plos One|April 25, 2014
A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderlyC Raina Macintyre, Iman Ridda, Zhanhai Gao, et al.
Molecular Psychiatry|December 2, 2021
Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomesZhi-De Deng, Miklos Argyelan, Jeremy Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
The role of the IL-2 pathway in costimulation blockade-resistant rejection of allograftsThomas R Jones, Jongwon Ha, Matthew A Williams, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 12, 2020
Electroconvulsive Therapy Pulse Amplitude and Clinical OutcomesChristopher C Abbott, Davin Quinn, Jeremy Miller, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B DiseaseGary W Zlotnick, Thomas R Jones, Paul Liberator, et al.
Vaccine|May 22, 2013
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccineLisa A Jackson, Alejandra Gurtman, Kathryn Rice, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2003
Thiourea inhibitors of herpes viruses. Part 1: bis-(aryl)thiourea inhibitors of CMVJonathan D Bloom, Martin J DiGrandi, Russell G Dushin, et al.
Journal of the Pediatric Infectious Diseases Society|January 25, 2016
Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy AdolescentsTimo Vesikari, Jacek Wysocki, Johannes Beeslaar, et al.
Pageof 7